The president-elect has boasted about the donations for his inauguration, library and political activities from those seeking ...

Shares of Rocket Lab soared by 361% last year, making it a top performer in the aerospace and defense industry.

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

It specifies that by 2035, China expects to fully ensure the safety, efficacy and accessibility of drugs and medical devices, ...

Structure Therapeutics has a strong cash position with a runway of 18-20 quarters, but the drug's potential is not fully ...

Artificial Intelligence (AI) continues to be a transformative force in 2024, reshaping industries, governance, and human ...

To study and analyze the Vietnam market size (value and volume) by company, key regions/countries, products and application, history data from 2023 to 2032, and forecast to 2032. To understand the ...

From PBMs to abortion, there are plenty of health policy issues that will vie for the spotlight in 2025. For pharma marketers ...

And right now, the defining issue of our time is that we are moving rapidly toward an oligarchic and authoritarian society in ...

Most change management is stunningly ineffective. Here's a middle-out approach that could improve your outcomes.

Right now, Novo stock is trading at a forward price-to-earnings (P/E) multiple of 22.5 -- its lowest level in well over a year. I think now is a terrific opportunity to scoop up shares of Novo on the ...